Endo International | ENDP - Ativos



Ativos Alterar Data
AbbVie USD 136.46B 2.5B 2026-03
Amarin USD 645.76M 25.01M 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Heron Therapeutics USD 246.22M 9.66M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Ligand Pharmaceuticals USD 1.53B 28.53M 2026-03
Merck USD 128.68B 8.18B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 207.62B 542M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Takeda JPY 15.45T 44.34B 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03
Zoetis USD 15.15B 313M 2026-03